Milestone Scientific (MLSS) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
5 Jun, 2026Executive summary
Annual Meeting scheduled for July 27, 2026, to be held virtually, allowing shareholders to vote and submit questions online.
Key proposals include director elections, amendments to increase authorized shares and equity plan shares, say-on-pay advisory vote, and auditor ratification.
Record date for voting is May 28, 2026, with 88,449,412 shares outstanding as of that date.
Proxy materials are distributed electronically to reduce costs and environmental impact.
Voting matters and shareholder proposals
Proposals: elect five directors, increase authorized common stock to 135,000,000, amend equity plan to 28,750,000 shares, advisory say-on-pay, ratify Grassi & Co. as auditors, and other business.
Only auditor ratification is considered a routine matter for broker voting; all other proposals require direct shareholder instruction.
Majority of votes cast required for approval of all proposals except director elections, which use plurality voting.
Board recommends voting in favor of all proposals.
Board of directors and corporate governance
Board consists of six members, four of whom are independent; five are nominated for re-election.
Board leadership is separated between Chairman and CEO roles to enhance governance and oversight.
Committees: Audit, Compensation, and Nominating & Corporate Governance, each with defined charters and independent members.
Audit Committee chaired by Benedetta Casamento, who is also designated as the audit committee financial expert.
Board has established processes for shareholder communication and compliance with Section 16(a) reporting.
Latest events from Milestone Scientific
- Q2 revenue up 22%, medical sales soared 231%, net loss narrowed, 2026 growth guidance reaffirmed.MLSS
Q2 2026 - All proposals passed, reinforcing growth focus and executive alignment with performance goals.MLSS
AGM 2026 - Shareholders will vote on director elections, equity plan expansion, and key governance proposals.MLSS
Proxy filing - Virtual meeting to vote on directors, share increases, equity plan, pay, and auditor ratification.MLSS
Proxy filing - Resale registration for 15.9M shares after $2.15M private placement; faces funding and compliance risks.MLSS
Registration filing - Q1 2026 saw stable revenue, sharply reduced losses, and improved liquidity amid ongoing risks.MLSS
Q1 2026 - 2026 guidance projects double-digit growth and major CompuFlo gains, targeting break even by 2027.MLSS
Q4 2025 - Q3 2025 saw stable revenue, reduced costs, and improved net loss amid ongoing financial uncertainty.MLSS
Q3 2025 - Q2 net income turned positive on a $2M NOL sale, with strong e-commerce and margin gains.MLSS
Q2 2024